X
20
Lupin Limited Mumbai In, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their significant offerings is Valsartan, supported by a 'Withdrawn by Holder' Certificate of Suitability (CEP) with the number R1-CEP 2012-274 - Rev 00
This Chemical Type CEP, issued on July 04, 2019, remains in force until February 21, 2022, ensuring its reliability within the pharmaceutical industry.
Substance Number 2423 associated with this CEP further emphasizes